Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 43, Issue 6, 2001, Pages 335-337

  Couto, Claudia Alves ^a   Bittencourt, Paulo Lisboa ^a   Farias, Alberto Queiroz ^a   Lallee, Margareth Pauli ^a   Cançado, Eduardo Luiz Rachid ^a   Massarollo, Paulo Celso Bosco ^a   Mies, Sérgio ^a  

^a NONE

Author keywords

Acute hepatic rejection; Chronic hepatitis B; HBIg; Liver transplantation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; POLYCLONAL ANTIBODY; STEROID;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0035690569     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652001000600007     Document Type: Article

References (15)

1. ADAMS, D.H.; HUBSCHER, S.G., NEUBERGER, J.M. et al. - Reduced incidence of rejection in patients undergoing liver transplantation for chronic hepatitis B. Transplant. Proc., 23: 1436-1417, 1991.
2. DEMETRIS, A J.; BATTS, K.P.; DHILLON, A.P. et al. - Banff schema for grading liver allograft rejection: an international consensus document. Hepatology, 25: 658-666. 1997.
3. FARGES, O.; SALIBA, F.; FARHAMANT, H. et al. - Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology, 23: 240-248, 1996.
4. FERAY, C.; GIGOU, M.; SAMUEL, D. et al. - Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann. intern, Med., 128: 810-816, 1998.
5. +)2-mediated anti-complement activity. Clin. exp. Immunol., 110: 122-126, 1997.
6. LOK, A.S.; HEATHCOTE, E.J. & HOOFNAGLE, J.H. - Management of hepatitis B: 2000. Summary of a workshop. Gastroenterology, 120: 1828-1853, 2001.
7. SAMUEL, D., MULLER, R.; ALEXANDER, G. et al. - Liver transplantation in European patients with hepatitis B surface antigen. New Engl. J. Med., 329: 1842-1847, 1993.
8. SAWYER, R.G.; MCGORY, R.W.; GAFFEY, M.J. et al. - Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann. Surg., 227: 841-850, 1998.
9. SCHUSSLER, O.; GENEVAZ, D.; LATREMOUILLE, C. et al. - Intravenous immunoglobulins for therapeutic use contain anti-idiotypes against xenophile antibodies and prolong discordant graft survival. Clin. Immunol. Immunopath., 86: 183-191, 1998.
10. SIVASAI, K.S.; MOHANAKUMAR, T.; PHELAN, D. et al. - Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates. Clin. exp. Immunol., 119: 559-565, 2000.
11. TAYLOR, R.M. - Monoclonal and polyclonal antibodies: clinical aspects. Immunol. Lett., 29: 113-116, 1991.
12. TERRAULT, N. - Hepatitis B and liver transplantation. Clin. Liver Dis., 3: 389-415, 1999.
13. TERRAULT, N.A.; ZHOU, S.; COMBS, C. et al. - Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology, 24: 1327-1333, 1996
14. VIERLING, J.M. - Immunology of acute and chronic hepatic allograft rejection. Liver Transpl. Surg., 5(suppl. 1): S1-S20, 1999.
15. WIESNER, R.H.; DEMETRIS, J.; BELLE, S.H. et al. - Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology, 28: 638-645, 1998.